Superworth

Sherwin-Williams SHW

Chemicals - Specialty, Basic Materials
$345.34
−2.00%
Market cap
$83.8B
PE
31.8×
10y median 33.3×
Forward PE
26.9×
10y median 26.5×
Price to sales
3.4×
EV/EBIT
23.4×
Revenue, 12 months
$24.4B
+6% on a year ago
Net margin
11.0%
Free cash flow yield
3.8%

Sherwin-Williams trades at 31.8× trailing earnings, near its ten-year median. Revenue was $24.4B over the last twelve months, up 6% on a year earlier with a 11% net margin.

Charts

Financials

Income statement for SHW, by quarter
Income statementQ3 FY23Q4 FY23Q1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
$6.1B+1%$5.3B+0%$5.4B−1%$6.3B+1%$6.2B+1%$5.3B+1%$5.3B−1%$6.3B+1%$6.4B+3%$5.6B+6%$5.7B+7%$6.8B+8%
Cost of revenue$3.2B−7%$2.7B−10%$2.8B−6%$3.2B−5%$3.1B−2%$2.7B+1%$2.7B−3%$3.2B−0%$3.2B+3%$2.9B+6%$2.9B+5%$3.5B+8%
Gross profit$2.9B+13%$2.5B+14%$2.5B+5%$3.1B+7%$3B+4%$2.6B+1%$2.6B+1%$3.1B+2%$3.1B+3%$2.7B+5%$2.8B+9%$3.3B+7%
SG&A$1.8B+9%$1.9B+13%$1.8B+6%$1.8B+5%$1.9B+8%$1.9B+2%$1.8B−0%$2B+9%$2B+3%$1.9B+3%$2B+10%$2.1B+5%
$1.1B+11%$641.7M+8%$729.2M+2%$1.3B+13%$1.1B+3%$698.2M+9%$756.4M+4%$1.1B−12%$1.2B+4%$778.7M+12%$804.6M+6%$1.2B+12%
Interest expense$101.9M+1%$94.6M−13%$103M−6%$110.8M−1%$103.4M+2%$98.5M+4%$103.8M+1%$112.4M+1%$117.2M+13%$131.6M+34%$131.6M+27%$135.9M+21%
Pre-tax income$1B+15%$474M−4%$640M+4%$1.2B+16%$1B+1%$615.6M+30%$653M+2%$985.7M−16%$1.1B+4%$639M+4%$679.8M+4%$1.1B+13%
$247.5M+29%$117.8M+9%$134.8M−2%$283.5M+30%$216.6M−13%$135.5M+15%$149.1M+11%$231M−19%$227.4M+5%$162.2M+20%$145.1M−3%$268.9M+16%
Net income$761.5M+11%$356.2M−8%$505.2M+6%$889.9M+12%$806.2M+6%$480.1M+35%$503.9M−0%$754.7M−15%$833.1M+3%$476.8M−1%$534.7M+6%$843.6M+12%
$2.95+13%$1.39−6%$1.97+7%$3.50+14%$3.18+8%$1.90+37%$2.00+2%$3.00−14%$3.35+5%$1.92+1%$2.15+8%$3.43+14%
258.4M−1%256.8M−2%255.8M−2%254.2M−2%253.9M−2%252.6M−2%252.5M−1%251.3M−1%249M−2%248.9M−2%248.1M−2%246M−2%

Operating income: 72 periods, Q3 FY08 to Q2 FY26: not printed by the filing, worked out from its own lines.

EPS, diluted: 13 periods, Q2 FY08 to Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: 18 periods, Q4 FY08 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Estimates

Next earnings report: .

QuarterRevenueRangeEPSRangeAnalysts
Q3 FY26$6.8B$6.7B to $6.8B$3.69$3.52 to $3.8016
Q4 FY26$5.9B$5.9B to $6B$2.35$2.33 to $2.4415
Q1 FY27$5.9B$5.8B to $6B$2.45$2.27 to $3.008
Q2 FY27$7.1B$7B to $7.2B$4.01$3.93 to $4.074
Q3 FY27$7.1B$7B to $7.2B$4.05$3.96 to $4.113
Q4 FY27$6.1B$6B to $6.2B$2.66$2.60 to $2.704
Q1 FY28$6.3B$6.2B to $6.3B$2.77$2.71 to $2.814
Q2 FY28$7.4B$7.3B to $7.5B$4.50$4.41 to $4.565

Peers

Companies in Chemicals - Specialty nearest Sherwin-Williams' size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
SHWSherwin-Williams$84B31.9×33.3×27.0×3.4×+6%11.0%
ECLEcolab$85.7B41.1×37.4×35.5×5.1×+7%12.6%
APDAir Products and Chemicals$69.9Bn/m28.1×22.1×5.5×+5%−0.4%
LINLinde$237.7B34.3×34.4×26.9×6.6×+8%19.3%
PPGPPG Industries$27.6B17.8×23.9×15.1×1.7×+5%9.6%
IFFInternational Flavors & Fragrances$23.8B81.9×35.9×27.0×2.4×−5%2.9%
LYBLyondellBasell Industries$21.4Bn/m9.2×9.2×0.7×−2%−1.1%
RPMRPM International$13.7B20.0×25.5×n/m1.7×+6%8.7%
CLXClorox$10.9B18.7×26.3×n/m1.6×−5%8.7%
Peer median$25.7B27.1×27.2×24.5×2.1×+5%8.7%

Investors who own it

Investors we follow who held Sherwin-Williams at the end of Jun 30, 2026, from their 13F filings.

More on Sherwin-Williams

Each number over time

Where it ranks

Its groups

About

Industry
Chemicals - Specialty
Sector
Basic Materials

Valuation data, not investment advice. Prices as of .